Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.19% rallied 3.27% to $176.78 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +2.16% rising 0.62% to 13,128.05 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.97% rising 0.45% to 33,912.44. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $288.07 below its 52-week high ($464.85), which the company reached on September 10th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +2.09% fell 0.22% to $142.29, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +2.25% rose 1.08% to $251.08, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.81% rose 0.26% to $66.81. Trading volume (4.9 M) remained 176,601 below its 50-day average volume of 5.1 M.